Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-24T17:23:46.659Z Has data issue: false hasContentIssue false
  • English
  • Français

Monoamines in Affective Illness: Is There a Place for 5HT?

Published online by Cambridge University Press:  29 January 2018

Donald Eccleston
Get access Rights & Permissions [Opens in a new window]

Extract

In a recent review of the structure and function of aminergic systems Iversen (1980) paid particular attention to the dopaminergic (DA) and noradrenergic neurones (NA) and only mentioned in passing those with 5HT as a transmitter. Although the original work on the low concentration of 5HIAA, the metabolite of 5HT, in CSF of depressed patients (Ashcroft et al, 1966) which brought serotonin to the attention of biological psychiatrists may not have stood the test of time, nevertheless, recent information on the behavioural consequences in animals of drugs and lesions which influence the output of the 5HT system suggests it plays a role in the development of pathological mood and behaviour in affective illness. This is reflected in the resurgence of clinical interest in antidepressant drugs designed to affect specifically the 5HT system and emphasizes the need to continue animal and clinical exploratory experiments on serotonergic function.

Type
Comments
Information
The British Journal of Psychiatry , Volume 138 , Issue 3 , March 1981 , pp. 257 - 258
Copyright
Copyright © Royal College of Psychiatrists, 1981 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aghajanian, G. F. & Wang, R. Y. (1978) Physiology and pharmacology of central serotonergic neurons. In A Generation of Progress (eds. M. A. Lipton, A. DiMascio and K. F. Killam). New York: Raven Press.Google Scholar
Ashcroft, G. W. Crawford, T. B. B. Eccleston, D. Sharman, D. F. Macdougall, E. J. Stanton, J. B. & Binns, J. K. (1966) 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet, ii, 1049–1052.Google Scholar
Baran, L. Maj, J. Regoz, Z. & Skuza, G (1979) On the central antiserotonin action of trazodone. Polish Journal of Pharmacology and Pharmacy, 21, 25–33.Google Scholar
Crow, T. J. (1973) Catecholamine-containing neurones and electrical self-stimulation: 2. A theoretical interpretation and some psychiatric implications. Psychological Medicine, 3, 66–73.Google Scholar
Dray, A. Gonye, T. J. Oakley, N. R. & Tanner, T. (1976) Evidence for the existence of a raphe projection to the substantia nigra in rat. Brain Research, 113, 45–57.Google Scholar
Eccleston, D. (1975) Modern views on diagnosis and classification of depression. Journal of International Medical Research, 3, 3–6.Google Scholar
Ennis, C. Kemp, J. D. & Cox, B. (1981) Characterization of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. Journal of Neurochemistry (in press).CrossRefGoogle Scholar
Iversen, S. D. (1980) Brain chemistry and behaviour. Psychological Medicine, 10, 527–540.Google Scholar
Nicolaou, N. & Eccleston, D. (1978) The influence of L-tryptophan and monoamine oxidase inhibitors on catecholamine metabolism in rat brain. British Journal of Pharmacology, 64, 341–345.Google Scholar
Shillitoe, E. E. (1970) The effect of parachlorphenylalanine on social interaction of male rats. British Journal of Pharmacology, 38, 305–315.Google Scholar
Sttnus, L. Kelley, A. E. & Iversen, S. D. (1978) Increased spontaneous activity following substance P infusion into A10 dopaminergic area. Nature, 276, 616–618.CrossRefGoogle Scholar
Vogt, M. (1977) Some incidents in the search for chemical transmitters in the brain. Biochemical Society Transactions, 5, 1653–1658.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.